Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained

Objective Approximately 84 million people in the USA have pre-diabetes, but only a fraction of them receive proven effective therapies to prevent type 2 diabetes. We estimated the value of prioritizing individuals at highest risk of progression to diabetes for treatment, compared to non-targeted tre...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta diabetologica 2021-06, Vol.58 (6), p.707-722
Hauptverfasser:	Olchanski, Natalia, van Klaveren, David, Cohen, Joshua T., Wong, John B., Ruthazer, Robin, Kent, David M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Diabetes mellitus (non-insulin dependent) Internal Medicine Life span Lifestyles Medicine Medicine & Public Health Metabolic Diseases Metformin Original Article Prevention programs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!